Data as of Dec 17
| -0.94 / -1.50%|
The 3 analysts offering 12-month price forecasts for China Biologic Products Inc have a median target of 76.00, with a high estimate of 96.40 and a low estimate of 65.00. The median estimate represents a +22.76% increase from the last price of 61.91.
The current consensus among 3 polled investment analysts is to Buy stock in China Biologic Products Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.